Orphenadrine Citrate Extended-Release Tablets Rx

Select the drug indication to add to your list

Orphenadrine Citrate Extended-Release Tablets

Musculoskeletal pain
Only 4 drugs may be compared at once

Generic Name and Formulations:

Orphenadrine citrate 100mg; sust-rel tabs.

Select therapeutic use:

Indications for Orphenadrine Citrate Extended-Release Tablets:

Painful musculoskeletal conditions.

Adult:

100mg twice daily (AM and PM).

Children:

Not recommended.

Contraindications:

Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.

Warnings/Precautions:

Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.

See Also:

NORFLEX INJECTION

Pharmacological Class:

Anticholinergic.

Adverse Reactions:

Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.

Note:

Formerly known under the brand name Norflex.

Generic Availability:

Norflex inj (YES)

How Supplied:

Tabs—contact supplier; Amps (2mL)—6